APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Stability & Storage Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Stability & Storage Service Market Analysis and Forecast 2026-2032

17 January 2026190 pages

Choose your research edition.

Industry ResearchPharmaceutical Stability & Storage Service Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Stability & Storage Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Stability & Storage Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Stability & Storage Service Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Stability & Storage Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pharmaceutical Stability & Storage Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Stability & Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Stability & Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Stability & Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Stability & Storage Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Stability & Storage Service include Almac, Auriga Research, Boston Analytical, Catalent, Element, Eurofins Scientific, Intertek, Masy BioServices and Precision Stability Storage, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Stability & Storage Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Stability & Storage Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Stability & Storage Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Stability & Storage Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Stability & Storage Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Stability & Storage Service revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Stability & Storage Service Segment by Company

Almac

Auriga Research

Boston Analytical

Catalent

Element

Eurofins Scientific

Intertek

Masy BioServices

Precision Stability Storage

Q1 Scientific

SGS

Pharmaceutical Stability & Storage Service Segment by Type

Pharmaceutical Stability Service

Pharmaceutical Storage Service

Pharmaceutical Stability & Storage Service Segment by Application

Macromolecular Pharmaceuticals

Small Molecule Pharmaceuticals

Bio-pharmacy

Other

Pharmaceutical Stability & Storage Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Stability & Storage Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Stability & Storage Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Stability & Storage Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Stability & Storage Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Stability & Storage Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Stability & Storage Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Stability & Storage Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmaceutical Stability Service Major Player Table 3. Pharmaceutical Storage Service Major Player Table 4. Global Pharmaceutical Stability & Storage Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Macromolecular Pharmaceuticals Major Player Table 6. Small Molecule Pharmaceuticals Major Player Table 7. Bio-pharmacy Major Player Table 8. Other Major Player Table 9. Pharmaceutical Stability & Storage Service Industry Trends Table 10. Pharmaceutical Stability & Storage Service Industry Drivers Table 11. Pharmaceutical Stability & Storage Service Industry Opportunities and Challenges Table 12. Pharmaceutical Stability & Storage Service Industry Restraints Table 13. Global Pharmaceutical Stability & Storage Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Stability & Storage Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Stability & Storage Service Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Stability & Storage Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Stability & Storage Service Market Share by Region (2027-2032) Table 18. Global Pharmaceutical Stability & Storage Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Players (2021-2026) Table 20. Global Pharmaceutical Stability & Storage Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmaceutical Stability & Storage Service Key Players Headquarters & Area Served Table 22. Global Pharmaceutical Stability & Storage Service Players, Product Type & Application Table 23. Global Pharmaceutical Stability & Storage Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmaceutical Stability & Storage Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pharmaceutical Stability & Storage Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Type (2021-2026) Table 30. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Type (2027-2032) Table 31. Global Pharmaceutical Stability & Storage Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Application (2021-2026) Table 35. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Application (2027-2032) Table 36. Almac Company Information Table 37. Almac Business Overview Table 38. Almac Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Almac Pharmaceutical Stability & Storage Service Product Portfolio Table 40. Almac Recent Development Table 41. Auriga Research Company Information Table 42. Auriga Research Business Overview Table 43. Auriga Research Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Auriga Research Pharmaceutical Stability & Storage Service Product Portfolio Table 45. Auriga Research Recent Development Table 46. Boston Analytical Company Information Table 47. Boston Analytical Business Overview Table 48. Boston Analytical Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Boston Analytical Pharmaceutical Stability & Storage Service Product Portfolio Table 50. Boston Analytical Recent Development Table 51. Catalent Company Information Table 52. Catalent Business Overview Table 53. Catalent Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Catalent Pharmaceutical Stability & Storage Service Product Portfolio Table 55. Catalent Recent Development Table 56. Element Company Information Table 57. Element Business Overview Table 58. Element Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Element Pharmaceutical Stability & Storage Service Product Portfolio Table 60. Element Recent Development Table 61. Eurofins Scientific Company Information Table 62. Eurofins Scientific Business Overview Table 63. Eurofins Scientific Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Eurofins Scientific Pharmaceutical Stability & Storage Service Product Portfolio Table 65. Eurofins Scientific Recent Development Table 66. Intertek Company Information Table 67. Intertek Business Overview Table 68. Intertek Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Intertek Pharmaceutical Stability & Storage Service Product Portfolio Table 70. Intertek Recent Development Table 71. Masy BioServices Company Information Table 72. Masy BioServices Business Overview Table 73. Masy BioServices Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Masy BioServices Pharmaceutical Stability & Storage Service Product Portfolio Table 75. Masy BioServices Recent Development Table 76. Precision Stability Storage Company Information Table 77. Precision Stability Storage Business Overview Table 78. Precision Stability Storage Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Precision Stability Storage Pharmaceutical Stability & Storage Service Product Portfolio Table 80. Precision Stability Storage Recent Development Table 81. Q1 Scientific Company Information Table 82. Q1 Scientific Business Overview Table 83. Q1 Scientific Pharmaceutical Stability & Storage Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Q1 Scientific Pharmaceutical Stability & Storage Service Product Portfolio Table 85. Q1 Scientific Recent Development Table 86. SGS Company Information Table 87. SGS Business Overview Table 88. SGS Pharmaceutical Stability & Storage Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. SGS Pharmaceutical Stability & Storage Service Product Portfolio Table 90. SGS Recent Development Table 91. North America Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Pharmaceutical Stability & Storage Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Pharmaceutical Stability & Storage Service Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Pharmaceutical Stability & Storage Service Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Pharmaceutical Stability & Storage Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Pharmaceutical Stability & Storage Service Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Pharmaceutical Stability & Storage Service Revenue by Country (US$ Million) & (2027-2032) Table 105. China Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 106. China Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 107. China Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 108. China Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Pharmaceutical Stability & Storage Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Pharmaceutical Stability & Storage Service Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Pharmaceutical Stability & Storage Service Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Pharmaceutical Stability & Storage Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Pharmaceutical Stability & Storage Service Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Pharmaceutical Stability & Storage Service Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Pharmaceutical Stability & Storage Service Image Figure 2. Global Pharmaceutical Stability & Storage Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Stability & Storage Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceutical Stability Service Image Figure 5. Pharmaceutical Storage Service Image Figure 6. Global Pharmaceutical Stability & Storage Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pharmaceutical Stability & Storage Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Macromolecular Pharmaceuticals Image Figure 9. Small Molecule Pharmaceuticals Image Figure 10. Bio-pharmacy Image Figure 11. Other Image Figure 12. Global Pharmaceutical Stability & Storage Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Pharmaceutical Stability & Storage Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Stability & Storage Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Stability & Storage Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pharmaceutical Stability & Storage Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Stability & Storage Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Type (2021-2032) Figure 20. Global Pharmaceutical Stability & Storage Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pharmaceutical Stability & Storage Service Revenue Market Share by Application (2021-2032) Figure 23. North America Pharmaceutical Stability & Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032) Figure 25. North America Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032) Figure 26. North America Pharmaceutical Stability & Storage Service Revenue Share by Country (2021-2032) Figure 27. United States Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pharmaceutical Stability & Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032) Figure 32. Europe Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032) Figure 33. Europe Pharmaceutical Stability & Storage Service Revenue Share by Country (2021-2032) Figure 34. Germany Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pharmaceutical Stability & Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032) Figure 44. China Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032) Figure 45. Asia Pharmaceutical Stability & Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032) Figure 47. Asia Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032) Figure 48. Asia Pharmaceutical Stability & Storage Service Revenue Share by Region (2021-2032) Figure 49. Japan Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pharmaceutical Stability & Storage Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Pharmaceutical Stability & Storage Service Revenue Share by Country (2021-2032) Figure 59. Brazil Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pharmaceutical Stability & Storage Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Stability Service
  • Pharmaceutical Storage Service
Applications
  • Macromolecular Pharmaceuticals
  • Small Molecule Pharmaceuticals
  • Bio-pharmacy
  • Other
Companies covered
  • Almac
  • Auriga Research
  • Boston Analytical
  • Catalent
  • Element
  • Eurofins Scientific
  • Intertek
  • Masy BioServices
  • Precision Stability Storage
  • Q1 Scientific
  • SGS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Stability & Storage Service Market by Type
  3. 1.2.1 Global Pharmaceutical Stability & Storage Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceutical Stability Service
  5. 1.2.3 Pharmaceutical Storage Service
  6. 1.3 Pharmaceutical Stability & Storage Service Market by Application
  7. 1.3.1 Global Pharmaceutical Stability & Storage Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Macromolecular Pharmaceuticals
  9. 1.3.3 Small Molecule Pharmaceuticals
  10. 1.3.4 Bio-pharmacy
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pharmaceutical Stability & Storage Service Market Dynamics
  1. 2.1 Pharmaceutical Stability & Storage Service Industry Trends
  2. 2.2 Pharmaceutical Stability & Storage Service Industry Drivers
  3. 2.3 Pharmaceutical Stability & Storage Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Stability & Storage Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Stability & Storage Service Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Stability & Storage Service Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Stability & Storage Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Stability & Storage Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Stability & Storage Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Stability & Storage Service Revenue by Players
  2. 4.1.1 Global Pharmaceutical Stability & Storage Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Stability & Storage Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Stability & Storage Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Stability & Storage Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Stability & Storage Service Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Stability & Storage Service Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Stability & Storage Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Stability & Storage Service Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Stability & Storage Service Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Stability & Storage Service Market Size by Type
  1. 5.1 Global Pharmaceutical Stability & Storage Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Stability & Storage Service Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Stability & Storage Service Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Stability & Storage Service Market Size by Application
  1. 6.1 Global Pharmaceutical Stability & Storage Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Stability & Storage Service Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Stability & Storage Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Almac
  2. 7.1.1 Almac Company Information
  3. 7.1.2 Almac Business Overview
  4. 7.1.3 Almac Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Almac Pharmaceutical Stability & Storage Service Product Portfolio
  6. 7.1.5 Almac Recent Developments
  7. 7.2 Auriga Research
  8. 7.2.1 Auriga Research Company Information
  9. 7.2.2 Auriga Research Business Overview
  10. 7.2.3 Auriga Research Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Auriga Research Pharmaceutical Stability & Storage Service Product Portfolio
  12. 7.2.5 Auriga Research Recent Developments
  13. 7.3 Boston Analytical
  14. 7.3.1 Boston Analytical Company Information
  15. 7.3.2 Boston Analytical Business Overview
  16. 7.3.3 Boston Analytical Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Boston Analytical Pharmaceutical Stability & Storage Service Product Portfolio
  18. 7.3.5 Boston Analytical Recent Developments
  19. 7.4 Catalent
  20. 7.4.1 Catalent Company Information
  21. 7.4.2 Catalent Business Overview
  22. 7.4.3 Catalent Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Catalent Pharmaceutical Stability & Storage Service Product Portfolio
  24. 7.4.5 Catalent Recent Developments
  25. 7.5 Element
  26. 7.5.1 Element Company Information
  27. 7.5.2 Element Business Overview
  28. 7.5.3 Element Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Element Pharmaceutical Stability & Storage Service Product Portfolio
  30. 7.5.5 Element Recent Developments
  31. 7.6 Eurofins Scientific
  32. 7.6.1 Eurofins Scientific Company Information
  33. 7.6.2 Eurofins Scientific Business Overview
  34. 7.6.3 Eurofins Scientific Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Eurofins Scientific Pharmaceutical Stability & Storage Service Product Portfolio
  36. 7.6.5 Eurofins Scientific Recent Developments
  37. 7.7 Intertek
  38. 7.7.1 Intertek Company Information
  39. 7.7.2 Intertek Business Overview
  40. 7.7.3 Intertek Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Intertek Pharmaceutical Stability & Storage Service Product Portfolio
  42. 7.7.5 Intertek Recent Developments
  43. 7.8 Masy BioServices
  44. 7.8.1 Masy BioServices Company Information
  45. 7.8.2 Masy BioServices Business Overview
  46. 7.8.3 Masy BioServices Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Masy BioServices Pharmaceutical Stability & Storage Service Product Portfolio
  48. 7.8.5 Masy BioServices Recent Developments
  49. 7.9 Precision Stability Storage
  50. 7.9.1 Precision Stability Storage Company Information
  51. 7.9.2 Precision Stability Storage Business Overview
  52. 7.9.3 Precision Stability Storage Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Precision Stability Storage Pharmaceutical Stability & Storage Service Product Portfolio
  54. 7.9.5 Precision Stability Storage Recent Developments
  55. 7.10 Q1 Scientific
  56. 7.10.1 Q1 Scientific Company Information
  57. 7.10.2 Q1 Scientific Business Overview
  58. 7.10.3 Q1 Scientific Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Q1 Scientific Pharmaceutical Stability & Storage Service Product Portfolio
  60. 7.10.5 Q1 Scientific Recent Developments
  61. 7.11 SGS
  62. 7.11.1 SGS Company Information
  63. 7.11.2 SGS Business Overview
  64. 7.11.3 SGS Pharmaceutical Stability & Storage Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 SGS Pharmaceutical Stability & Storage Service Product Portfolio
  66. 7.11.5 SGS Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Stability & Storage Service Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Stability & Storage Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Stability & Storage Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Stability & Storage Service Revenue by Country
  11. 8.6.1 North America Pharmaceutical Stability & Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Stability & Storage Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Stability & Storage Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Stability & Storage Service Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Stability & Storage Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Stability & Storage Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Stability & Storage Service Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Stability & Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Stability & Storage Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Stability & Storage Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Stability & Storage Service Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Stability & Storage Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Stability & Storage Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Stability & Storage Service Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Stability & Storage Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Stability & Storage Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Stability & Storage Service Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Stability & Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Stability & Storage Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Stability & Storage Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Stability & Storage Service Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Stability & Storage Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Stability & Storage Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Stability & Storage Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Stability & Storage Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Stability & Storage Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Stability & Storage Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Stability & Storage Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Stability & Storage Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Stability & Storage Service Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Stability & Storage Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Stability & Storage Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Stability & Storage Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst